Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin.
Kameda K, Kako S, Hayakawa J, Akahoshi Y, Komiya Y, Harada N, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Kanda J, Tanihara A, Wada H, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kanda Y. Kameda K, et al. Among authors: kikuchi m. Ann Hematol. 2018 Jan;97(1):169-179. doi: 10.1007/s00277-017-3141-4. Epub 2017 Sep 30. Ann Hematol. 2018. PMID: 28965134
Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation.
Ishida Y, Terasako K, Oshima K, Sakamoto K, Ashizawa M, Sato M, Kikuchi M, Kimura S, Nakasone H, Okuda S, Kako S, Yamazaki R, Nishida J, Kanda Y. Ishida Y, et al. Among authors: kikuchi m. Int J Hematol. 2010 Oct;92(3):542-6. doi: 10.1007/s12185-010-0678-6. Epub 2010 Sep 8. Int J Hematol. 2010. PMID: 20824399
Association between serum high-molecular-weight adiponectin level and the severity of chronic graft-versus-host disease in allogeneic stem cell transplantation recipients.
Nakasone H, Binh PN, Yamazaki R, Tanaka Y, Sakamoto K, Ashizawa M, Sato M, Terasako K, Kimura S, Kikuchi M, Kako S, Okuda S, Oshima K, Tanihara A, Nishida J, Abe Y, Kanda Y. Nakasone H, et al. Among authors: kikuchi m. Blood. 2011 Mar 24;117(12):3469-72. doi: 10.1182/blood-2010-10-316109. Epub 2011 Jan 21. Blood. 2011. PMID: 21258011 Free article.
Protection of ovarian function by two distinct methods of ovarian shielding for young female patients who receive total body irradiation.
Kanda Y, Wada H, Yamasaki R, Kawamura K, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako-Saito K, Kimura S, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Nishida J, Tsunoda H, Omori Y, Nakazawa M, Tanaka O. Kanda Y, et al. Among authors: kikuchi m. Ann Hematol. 2014 Feb;93(2):287-92. doi: 10.1007/s00277-013-1852-8. Epub 2013 Jul 28. Ann Hematol. 2014. PMID: 23892927 Clinical Trial.
The safety and efficacy of acute graft-versus-host disease prophylaxis with a higher target blood concentration of cyclosporine around 500 ng/mL.
Machishima T, Kako S, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako K, Kimura S, Kikuchi M, Nakasone H, Kanda J, Yamazaki R, Nishida J, Kanda Y. Machishima T, et al. Among authors: kikuchi m. Clin Transplant. 2013 Sep-Oct;27(5):749-56. doi: 10.1111/ctr.12213. Epub 2013 Aug 20. Clin Transplant. 2013. PMID: 24033855
Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation.
Kawamura K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y. Kawamura K, et al. Among authors: kikuchi m. Int J Infect Dis. 2014 Feb;19:26-32. doi: 10.1016/j.ijid.2013.09.020. Epub 2013 Nov 6. Int J Infect Dis. 2014. PMID: 24211377 Free article.
A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia.
Ashizawa M, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako K, Kimura S, Kikuchi M, Nakasone H, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y. Ashizawa M, et al. Among authors: kikuchi m. Int J Hematol. 2014 Mar;99(3):311-7. doi: 10.1007/s12185-014-1501-6. Epub 2014 Feb 1. Int J Hematol. 2014. PMID: 24488782
Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials.
Kimura S, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y. Kimura S, et al. Among authors: kikuchi m. J Infect. 2014 Jul;69(1):13-25. doi: 10.1016/j.jinf.2014.02.013. Epub 2014 Feb 26. J Infect. 2014. PMID: 24583063 Review.
Severe oral infection due to Lactobacillus rhamnosus during induction chemotherapy for acute myeloid leukemia.
Ishihara Y, Kanda J, Tanaka K, Nakano H, Ugai T, Wada H, Yamasaki R, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kako S, Nishida J, Watanabe K, Kanda Y. Ishihara Y, et al. Among authors: kikuchi m. Int J Hematol. 2014 Dec;100(6):607-10. doi: 10.1007/s12185-014-1650-7. Epub 2014 Aug 13. Int J Hematol. 2014. PMID: 25115834
Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantation.
Sato M, Kako S, Matsumoto K, Oshima K, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Wada H, Ishihara Y, Sakamoto K, Kawamura K, Ashizawa M, Terasako-Saito K, Kimura S, Nakasone H, Kikuchi M, Tanihara A, Yamazaki R, Tanaka Y, Kanda J, Nishida J, Morita K, Kanda Y. Sato M, et al. Among authors: kikuchi m. Int J Hematol. 2015 May;101(5):497-504. doi: 10.1007/s12185-015-1756-6. Epub 2015 Feb 12. Int J Hematol. 2015. PMID: 25672602
3,116 results